GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » Cash And Cash Equivalents

Qianhai Health Holdings (HKSE:00911) Cash And Cash Equivalents : HK$19.5 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings Cash And Cash Equivalents?

Qianhai Health Holdings's quarterly cash and cash equivalents increased from Dec. 2022 (HK$1.64 Mil) to Jun. 2023 (HK$9.17 Mil) and increased from Jun. 2023 (HK$9.17 Mil) to Dec. 2023 (HK$19.53 Mil).

Qianhai Health Holdings's annual cash and cash equivalents declined from Dec. 2021 (HK$2.47 Mil) to Dec. 2022 (HK$1.64 Mil) but then increased from Dec. 2022 (HK$1.64 Mil) to Dec. 2023 (HK$19.53 Mil).


Qianhai Health Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Qianhai Health Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianhai Health Holdings Cash And Cash Equivalents Chart

Qianhai Health Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.00 16.37 2.47 1.64 19.53

Qianhai Health Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.47 163.43 1.64 9.17 19.53

Qianhai Health Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Qianhai Health Holdings  (HKSE:00911) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Qianhai Health Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianhai Health Holdings (HKSE:00911) Business Description

Traded in Other Exchanges
N/A
Address
177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.
Executives
Huang Guanchao 2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited 2501 Other
Hou Chung Man 2501 Other
Tang Chung Wah 2501 Other
Sparkling Rock Limited 2201 Interest of corporation controlled by you
Chong Siew Hoong 2202 Interest of your spouse
Lim Tzea 2101 Beneficial owner
Explorer Rosy Limited
Great Prosperous Limited
Noble Stand Global Limited
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited 2106 Person having a security interest in shares
Yunnan International Holding Group Limited 2106 Person having a security interest in shares
Yunnan International Supply Chain Limited 2106 Person having a security interest in shares
Yunnan Provincial Energy Investment Group Co., Ltd 2106 Person having a security interest in shares

Qianhai Health Holdings (HKSE:00911) Headlines

No Headlines